Transcripts Bristol-Myers Squibb Company Xetra

Actions

BRM

US1101221083

Temps réel estimé Tradegate Autres places de cotation 14:02:34 20/06/2024			Varia. 5j.	Varia. 1 janv.
38,12 ^EUR	-0,37%		-1,11%	-18,28%

19/06	Bristol Myers : l'ex-CEO d'Agilent rejoint le conseil	CF
18/06	Bristol Myers Squibb nomme Michael R. McMullen administrateur indépendant et membre du comité d'audit, à compter du 1er juillet 2024	CI

Transcripts

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Transcript : Bristol-Myers Squibb Company Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-11-2024 11:20 AM	11/06
Transcript : Bristol-Myers Squibb Company Presents at Bank of America Health Care Conference 2024, May-15-2024 11:20 AM	15/05
Transcript : Bristol-Myers Squibb Company Presents at Guggenheim Securities Radiopharmaceuticals Day, May-13-2024 11:00 AM	13/05
Transcript : Bristol-Myers Squibb Company, Q1 2024 Earnings Call, Apr 25, 2024	25/04
Transcript : Bristol-Myers Squibb Company Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-14-2024 08:30 AM	14/03
Transcript : Bristol-Myers Squibb Company Presents at Leerink Partners Global Biopharma Conference 2024, Mar-13-2024 10:00 AM	13/03
Transcript : Bristol-Myers Squibb Company Presents at TD Cowen 44th Annual Health Care Conference 2024, Mar-04-2024 09:50 AM	04/03
Transcript : Bristol-Myers Squibb Company, Q4 2023 Earnings Call, Feb 02, 2024	02/02
Transcript : Bristol-Myers Squibb Company Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 07:30 AM	08/01
Transcript : Bristol-Myers Squibb Company Presents at Goldman Sachs Healthcare C-Suite Unscripted Conference, Jan-04-2024 11:00 AM	04/01
Transcript : Bristol-Myers Squibb Company, Karuna Therapeutics, Inc. - M&A Call	22/12
Transcript : Bristol-Myers Squibb Company Presents at 14th Annual Jefferies London Healthcare Conference 2023, Nov-16-2023 09:30 AM	16/11
Transcript : Bristol-Myers Squibb Company Presents at UBS Biopharma Conference 2023, Nov-08-2023 08:00 AM	08/11
Transcript : Bristol-Myers Squibb Company, Q3 2023 Earnings Call, Oct 26, 2023	26/10/23
Transcript : Bristol-Myers Squibb Company - Special Call	14/09/23
Transcript : Bristol-Myers Squibb Company Presents at Morgan Stanley 21st Annual Global Healthcare Conference 2023, Sep-11-2023 08:00 AM	11/09/23
Transcript : Bristol-Myers Squibb Company, Q2 2023 Earnings Call, Jul 27, 2023	27/07/23
Transcript : Bristol-Myers Squibb Company Presents at Goldman Sachs 44th Annual Global Healthcare Conference, Jun-13-2023 08:40 AM	13/06/23
Transcript : Bristol-Myers Squibb Company Presents at Jefferies 2023 Global Healthcare Conference, Jun-08-2023 09:00 AM	08/06/23
Transcript : Bristol-Myers Squibb Company Presents at 2023 American Society of Clinical Oncology Annual Meeting, Jun-02-2023 through Jun-06-2023	02/06/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

A la une

Christopher Boerner, PDG de Bristol-Myers : Un pipeline de 16 traitements, focus sur les neurosciences et l'oncologie

Le 09 janvier 2024 à 19:06